This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN rallied 7.79% to $2.63 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 2.62% to 4,023.61 and the Dow Jones Industrial Average DJIA rising 1.37% to 32,197.59. Ocugen Inc. closed $15.02 below its 52-week high ($17.65), which the company reached on November 3rd.
The stock outperformed some of its competitors Wednesday, as Adverum Biotechnologies Inc. ADVM rose 3.87% to $1.61, Ocular Therapeutix Inc. OCUL rose 3.25% to $4.45, and Kodiak Sciences Inc. KOD rose 4.15% to $9.79. Trading volume (5.6 M) remained 917,824 below its 50-day average volume of 6.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2022.
(END) Dow Jones Newswires
July 27, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.